# CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy

> **NCT01378299** · PHASE1 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 105 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testosterone Cypionate

## Key facts

- **NCT ID:** NCT01378299
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-01
- **Primary completion:** 2016-11-07
- **Final completion:** 2017-11-07
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01378299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01378299, "CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01378299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*